USANA Health Sciences (NYSE:USNA) Shares Up 3.4% – Time to Buy?

USANA Health Sciences, Inc. (NYSE:USNA) shares traded up 3.4% during mid-day trading on Monday . The stock traded as high as $32.77 and last traded at $32.87. 32,805 shares were traded during trading, a decline of 75% from the average session volume of 130,944 shares. The stock had previously closed at $31.78.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on USNA. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, DA Davidson boosted their target price on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd.

USANA Health Sciences Stock Performance

The stock has a market capitalization of $632.26 million, a price-to-earnings ratio of 11.72, a PEG ratio of 0.93 and a beta of 0.87. The company has a 50 day moving average of $33.65 and a 200 day moving average of $36.64.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15. The firm had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. As a group, research analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. R Squared Ltd acquired a new position in shares of USANA Health Sciences during the 4th quarter worth about $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences during the 3rd quarter worth about $30,000. KBC Group NV boosted its position in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after acquiring an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of USANA Health Sciences during the 4th quarter worth about $83,000. Finally, Quantbot Technologies LP acquired a new position in shares of USANA Health Sciences during the 4th quarter worth about $132,000. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.